Skip to main content
. Author manuscript; available in PMC: 2018 Apr 6.
Published in final edited form as: Cancer Treat Rev. 2017 Apr 6;55:190–199. doi: 10.1016/j.ctrv.2017.03.010

Figure 2.

Figure 2

History of immunotherapeutic approaches in MM (marked in red). Abbr: Mel - Melphalan, MP - Melphalan/Prednisone, INF - Interferon, Dex - Dexamethasone, Thal - Thalidomide, BTZ - Bortezomib, RIC allo SCT - reduced intensity allogeneic stem cell transplantation, lip Doxo - liposomal Doxorubicin, Carf - Carfilzomib, Len - Lenalidomide, Poma – Pomalidomide